4-Fluoroamphetamine
-
4-Fluoroamphetamine structure diagram
-
4-Fluoroamphetamine ball-and-stick model
-
4-Fluoroamphetamine
4-Fluoroamphetamine[edit]
4-Fluoroamphetamine (4-FA), also known as para-fluoroamphetamine, is a synthetic amphetamine derivative. It is a member of the substituted amphetamines class, which are compounds that have a phenethylamine core with a methyl group attached to the alpha carbon and a fluorine atom substituted at the para position of the phenyl ring.
Chemical Structure and Properties[edit]
4-Fluoroamphetamine has the chemical formula C9H12FN. It is structurally similar to other amphetamines, with the key difference being the presence of a fluorine atom at the para position of the phenyl ring. This modification can significantly alter the pharmacological properties of the compound.
Pharmacology[edit]
4-Fluoroamphetamine acts primarily as a releasing agent of the monoamine neurotransmitters serotonin, dopamine, and norepinephrine. It is known to increase the release of these neurotransmitters from their storage sites in the presynaptic neuron, leading to increased concentrations in the synaptic cleft and enhanced neurotransmission.
The compound has been reported to have both stimulant and entactogenic effects, similar to those of MDMA and other related compounds. Users have described effects such as increased energy, euphoria, and enhanced sociability.
Legal Status[edit]
The legal status of 4-Fluoroamphetamine varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. In others, it may be unscheduled but subject to regulation under analog laws.
Potential Risks and Side Effects[edit]
As with other amphetamines, the use of 4-Fluoroamphetamine can pose several health risks. Potential side effects include increased heart rate, hypertension, anxiety, and insomnia. There is also a risk of neurotoxicity, particularly with high doses or prolonged use, due to the excessive release of serotonin and other neurotransmitters.
Synthesis[edit]
The synthesis of 4-Fluoroamphetamine typically involves the fluorination of a precursor compound, such as benzaldehyde, followed by reductive amination to introduce the amine group. The process requires careful control of reaction conditions to ensure the correct substitution pattern and to minimize the formation of byproducts.
Related Pages[edit]
- Amphetamine
- Substituted amphetamines
- Serotonin releasing agent
- Dopamine releasing agent
- Norepinephrine releasing agent
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian